DOYLE JOHN C 4
4 · CASTLIGHT HEALTH, INC. · Filed May 20, 2019
Insider Transaction Report
Form 4
DOYLE JOHN C
CFO, V.P. & Treasurer
Transactions
- Sale
Class B Common Stock
2019-05-17$3.40/sh−29,882$101,617→ 362,370 total - Exercise/Conversion
Restricted Stock Units
2019-05-16−23,750→ 261,250 totalExercise: $0.00→ Class B Common Stock (23,750 underlying) - Exercise/Conversion
Restricted Stock Units
2019-05-16−32,437→ 486,563 totalExercise: $0.00→ Class B Common Stock (32,437 underlying) - Exercise/Conversion
Class B Common Stock
2019-05-16+32,437→ 392,252 total - Exercise/Conversion
Restricted Stock Units
2019-05-16−7,812→ 23,438 totalExercise: $0.00→ Class B Common Stock (7,812 underlying) - Exercise/Conversion
Restricted Stock Units
2019-05-16−18,750→ 93,750 totalExercise: $0.00→ Class B Common Stock (18,750 underlying) - Exercise/Conversion
Class B Common Stock
2019-05-16+18,750→ 336,065 total - Exercise/Conversion
Class B Common Stock
2019-05-16+7,812→ 317,315 total - Exercise/Conversion
Class B Common Stock
2019-05-16+23,750→ 359,815 total
Footnotes (11)
- [F1]Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 4.
- [F10]The RSUs will vest in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
- [F11]The RSUs will vest in equal quarterly installments over four years, beginning on May 16, 2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
- [F2]Release and settlement of RSUs granted to the Reporting Person on July 8, 2016, the grant of which was previously reported by the Reporting Person on a Form 4.
- [F3]Release and settlement of RSUs granted to the Reporting Person on February 15, 2018, the grant of which was previously reported by the Reporting Person on a Form 4.
- [F4]Release and settlement of RSUs granted to the Reporting Person on April 5, 2019, the grant of which was previously reported by the Reporting Person on a Form 4.
- [F5]Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- [F6]Represents the weighted average sales price per share. The shares sold at prices ranging from $3.42 to $3.53 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F7]Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration.
- [F8]The RSUs vest over 4 years as follows: 25% of the RSUs vested on February 16, 2017 and the remainder will vest on each quarterly anniversary thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
- [F9]25% of the RSUs vested on August 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.